Cargando…
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease primarily characterized by loss of motor neurons in brain and spinal cord. The death of motor neurons leads to denervation of muscle which in turn causes muscle weakness and paralysis, decreased respiratory function and eventua...
Autores principales: | Tefera, Tesfaye W., Borges, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222822/ https://www.ncbi.nlm.nih.gov/pubmed/28119559 http://dx.doi.org/10.3389/fnins.2016.00611 |
Ejemplares similares
-
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
por: Tefera, Tesfaye Wolde, et al.
Publicado: (2021) -
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
por: Tafuri, Francesco, et al.
Publicado: (2015) -
Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015) -
Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis
por: Liu, Yu-Ju, et al.
Publicado: (2017) -
Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis
por: Brunet, Aurore, et al.
Publicado: (2020)